
|Articles|February 15, 2004
Ophthalmology gets with the program
As part of its commitment to the field of ophthalmology, Pfizer Inc. has developed and funded several philanthropic programs in the area of eye care.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Avisi Technologies treats first patient in SAPPHIRE trial for glaucoma
2
FDA approves Amneal Pharmaceuticals' cyclosporine ophthalmic emulsion 0.05%
3
Lotus submits NDA in South Korea for LENZ’s presbyopia treatment VIZZ
4
Inflammasome Therapeutics completes phase 2 trial enrollment for K8 in GA
5















































.png)


